Diabetic ketoacidosis and hyperglycemic hyperosmolar state are associated with higher in-hospital mortality and morbidity in diabetes patients hospitalized with ST-elevation myocardial infarction, but not within 30 days of readmission.

<h4>Background</h4>While the cardiovascular risk of hyperglycemia has been thoroughly elucidated in patients with type 2 diabetes (T2DM) hospitalized for myocardial infarction, the evidence surrounding acute severe hyperglycemia is less well-established. Our study aimed to explore the im...

Full description

Saved in:
Bibliographic Details
Main Authors: Turki Almutairi, Soha Dargham, Amin Jayyousi, Jassim Al Suwaidi, Charbel Abi Khalil
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0318774
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823856810260430848
author Turki Almutairi
Soha Dargham
Amin Jayyousi
Jassim Al Suwaidi
Charbel Abi Khalil
author_facet Turki Almutairi
Soha Dargham
Amin Jayyousi
Jassim Al Suwaidi
Charbel Abi Khalil
author_sort Turki Almutairi
collection DOAJ
description <h4>Background</h4>While the cardiovascular risk of hyperglycemia has been thoroughly elucidated in patients with type 2 diabetes (T2DM) hospitalized for myocardial infarction, the evidence surrounding acute severe hyperglycemia is less well-established. Our study aimed to explore the impact of diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS), both severe hyperglycemic conditions, on cardiovascular outcomes in patients with T2D admitted for ST-elevation myocardial infarction (STEMI).<h4>Methods</h4>We used the National Readmission Database (2016-2019) to extract patients with T2DM and STEMI at baseline. Subsequently, we selected cases of DKA and HHS. The primary endpoint was in-hospital mortality. Secondary endpoints included in-hospital acute renal failure, cardiogenic shock, and 30-day readmission and mortality.<h4>Results</h4>The presence of DKA increased the adjusted odds of mortality and cardiogenic shock by almost 2-fold (adjusted Odds Ratios aOR = 2.30 [1.70-3.12], 2.055 [1.602-2.637], respectively) and renal failure by nearly 5-fold (aOR = 5.175 [4.090-6.546]). HHS was also associated with higher odds of mortality, acute renal failure, and cardiogenic shock. In 30 days, DKA and HHS increased the risk of readmission (aOR = 1.815 [1.449-2.75], 1.751 [1.376-2.228], respectively). There were no differences in the rates of cardiovascular disease, mortality, or other cardiovascular events between DKA and HHS patients. Within 30 days of readmission, DKA and HHS were associated with higher odds of readmission but not mortality. Cardiovascular disease was the most common etiology of readmission in all patients. The incidence of non-STEMI was the highest in DKA patients, and the incidence of STEMI was the highest in the HHS group.<h4>Conclusion</h4>The presence of diabetic ketoacidosis or hyperglycemic hyperosmolar state is associated with higher odds of mortality, renal failure, cardiogenic shock, and 30-day readmission in STEMI patients with type 2 diabetes, highlighting the need for enhanced clinical management and monitoring of patients experiencing acute hyperglycemia.
format Article
id doaj-art-28fa5198d193433ba9ca0cd0be3f409a
institution Kabale University
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-28fa5198d193433ba9ca0cd0be3f409a2025-02-12T05:30:53ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01202e031877410.1371/journal.pone.0318774Diabetic ketoacidosis and hyperglycemic hyperosmolar state are associated with higher in-hospital mortality and morbidity in diabetes patients hospitalized with ST-elevation myocardial infarction, but not within 30 days of readmission.Turki AlmutairiSoha DarghamAmin JayyousiJassim Al SuwaidiCharbel Abi Khalil<h4>Background</h4>While the cardiovascular risk of hyperglycemia has been thoroughly elucidated in patients with type 2 diabetes (T2DM) hospitalized for myocardial infarction, the evidence surrounding acute severe hyperglycemia is less well-established. Our study aimed to explore the impact of diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS), both severe hyperglycemic conditions, on cardiovascular outcomes in patients with T2D admitted for ST-elevation myocardial infarction (STEMI).<h4>Methods</h4>We used the National Readmission Database (2016-2019) to extract patients with T2DM and STEMI at baseline. Subsequently, we selected cases of DKA and HHS. The primary endpoint was in-hospital mortality. Secondary endpoints included in-hospital acute renal failure, cardiogenic shock, and 30-day readmission and mortality.<h4>Results</h4>The presence of DKA increased the adjusted odds of mortality and cardiogenic shock by almost 2-fold (adjusted Odds Ratios aOR = 2.30 [1.70-3.12], 2.055 [1.602-2.637], respectively) and renal failure by nearly 5-fold (aOR = 5.175 [4.090-6.546]). HHS was also associated with higher odds of mortality, acute renal failure, and cardiogenic shock. In 30 days, DKA and HHS increased the risk of readmission (aOR = 1.815 [1.449-2.75], 1.751 [1.376-2.228], respectively). There were no differences in the rates of cardiovascular disease, mortality, or other cardiovascular events between DKA and HHS patients. Within 30 days of readmission, DKA and HHS were associated with higher odds of readmission but not mortality. Cardiovascular disease was the most common etiology of readmission in all patients. The incidence of non-STEMI was the highest in DKA patients, and the incidence of STEMI was the highest in the HHS group.<h4>Conclusion</h4>The presence of diabetic ketoacidosis or hyperglycemic hyperosmolar state is associated with higher odds of mortality, renal failure, cardiogenic shock, and 30-day readmission in STEMI patients with type 2 diabetes, highlighting the need for enhanced clinical management and monitoring of patients experiencing acute hyperglycemia.https://doi.org/10.1371/journal.pone.0318774
spellingShingle Turki Almutairi
Soha Dargham
Amin Jayyousi
Jassim Al Suwaidi
Charbel Abi Khalil
Diabetic ketoacidosis and hyperglycemic hyperosmolar state are associated with higher in-hospital mortality and morbidity in diabetes patients hospitalized with ST-elevation myocardial infarction, but not within 30 days of readmission.
PLoS ONE
title Diabetic ketoacidosis and hyperglycemic hyperosmolar state are associated with higher in-hospital mortality and morbidity in diabetes patients hospitalized with ST-elevation myocardial infarction, but not within 30 days of readmission.
title_full Diabetic ketoacidosis and hyperglycemic hyperosmolar state are associated with higher in-hospital mortality and morbidity in diabetes patients hospitalized with ST-elevation myocardial infarction, but not within 30 days of readmission.
title_fullStr Diabetic ketoacidosis and hyperglycemic hyperosmolar state are associated with higher in-hospital mortality and morbidity in diabetes patients hospitalized with ST-elevation myocardial infarction, but not within 30 days of readmission.
title_full_unstemmed Diabetic ketoacidosis and hyperglycemic hyperosmolar state are associated with higher in-hospital mortality and morbidity in diabetes patients hospitalized with ST-elevation myocardial infarction, but not within 30 days of readmission.
title_short Diabetic ketoacidosis and hyperglycemic hyperosmolar state are associated with higher in-hospital mortality and morbidity in diabetes patients hospitalized with ST-elevation myocardial infarction, but not within 30 days of readmission.
title_sort diabetic ketoacidosis and hyperglycemic hyperosmolar state are associated with higher in hospital mortality and morbidity in diabetes patients hospitalized with st elevation myocardial infarction but not within 30 days of readmission
url https://doi.org/10.1371/journal.pone.0318774
work_keys_str_mv AT turkialmutairi diabeticketoacidosisandhyperglycemichyperosmolarstateareassociatedwithhigherinhospitalmortalityandmorbidityindiabetespatientshospitalizedwithstelevationmyocardialinfarctionbutnotwithin30daysofreadmission
AT sohadargham diabeticketoacidosisandhyperglycemichyperosmolarstateareassociatedwithhigherinhospitalmortalityandmorbidityindiabetespatientshospitalizedwithstelevationmyocardialinfarctionbutnotwithin30daysofreadmission
AT aminjayyousi diabeticketoacidosisandhyperglycemichyperosmolarstateareassociatedwithhigherinhospitalmortalityandmorbidityindiabetespatientshospitalizedwithstelevationmyocardialinfarctionbutnotwithin30daysofreadmission
AT jassimalsuwaidi diabeticketoacidosisandhyperglycemichyperosmolarstateareassociatedwithhigherinhospitalmortalityandmorbidityindiabetespatientshospitalizedwithstelevationmyocardialinfarctionbutnotwithin30daysofreadmission
AT charbelabikhalil diabeticketoacidosisandhyperglycemichyperosmolarstateareassociatedwithhigherinhospitalmortalityandmorbidityindiabetespatientshospitalizedwithstelevationmyocardialinfarctionbutnotwithin30daysofreadmission